Tourmaline Bio, Inc., a Novartis Company

Works in Genetic & rare · Immunology · Metabolic & endocrine · Renal & urogenital · Women's health

Tourmaline Bio, Inc., a Novartis Company is a clinical trial sponsor. It has 1 active clinical trial with 79 planned participants, across 5 therapeutic areas. Since 2021 it has completed 1 trial and stopped 0 early.

Trial track record · since 2021

1Active trials79 planned participants
1Completed1 with results posted
0Stopped earlyterminated, withdrawn or suspended

Pipeline · 1 active trial

StageTrialStatus

Questions about Tourmaline Bio, Inc., a Novartis Company

See the rest of this profile

A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.

Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2026-08-11.

Approve Suite is not affiliated with Tourmaline Bio, Inc., a Novartis Company.

See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.